Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT
- Conditions
- Diabetic Macular Edema
- First Posted Date
- 2023-02-27
- Last Posted Date
- 2023-02-27
- Lead Sponsor
- Notal Vision Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT05745116
- Locations
- ๐บ๐ธ
Wagner Kapoor Research Institute, Norfolk, Virginia, United States
๐บ๐ธThe Retina Group of Washington, Fairfax, Virginia, United States
๐บ๐ธElman Retina Group, PA, Baltimore, Maryland, United States
ForeseeHome NRich Registry
- Conditions
- Age-Related Macular Degeneration
- First Posted Date
- 2023-01-19
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- Notal Vision Inc.
- Target Recruit Count
- 20000
- Registration Number
- NCT05690880
- Locations
- ๐บ๐ธ
NJ Retina, Toms River, New Jersey, United States
Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD
- Conditions
- Retinal Neovascularization
- First Posted Date
- 2022-12-14
- Last Posted Date
- 2023-05-22
- Lead Sponsor
- Notal Vision Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT05650047
- Locations
- ๐บ๐ธ
Pepose Vision Institute, Saint Louis, Missouri, United States
๐บ๐ธOphthalmic Cons. of Boston, Boston, Massachusetts, United States
๐บ๐ธPalmetto Retina Center, Florence, South Carolina, United States
Single In-Clinic Encounter With the Notal Vision Home OCT by DME Patients
- Conditions
- Diabetic Retinopathy
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Notal Vision Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT05417152
- Locations
- ๐ฎ๐ฑ
Assuta Hashalom, Tel Aviv, Israel
Home OCT Repeatability and Reproducibility of Automatic Fluid Quantification Study
- Conditions
- Neovascular Age-related Macular Degeneration
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2022-04-05
- Lead Sponsor
- Notal Vision Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT05281042
- Locations
- ๐บ๐ธ
Elman Retina Group, Glen Burnie, Maryland, United States
The Evaluation of the Agreement Between the NVHO in the Automatic Fluid Quantification and Cirrus OCT
- Conditions
- Neovascular Age-related Macular Degeneration
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- Notal Vision Inc.
- Target Recruit Count
- 386
- Registration Number
- NCT05202587
- Locations
- ๐บ๐ธ
Tennessee Retina, PC, Nashville, Tennessee, United States
๐บ๐ธBrian Joondeph, Lakewood, Colorado, United States
๐บ๐ธFlorida Retina Institute, PA, Orlando, Florida, United States
Home OCT Fluid Visualization Agreement Study
- Conditions
- Neovascular Age-related Macular Degeneration
- First Posted Date
- 2021-05-28
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- Notal Vision Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT04907409
- Locations
- ๐บ๐ธ
Elman Retina Group, P.A., Glen Burnie, Maryland, United States
๐บ๐ธOphthalmic Cons. of Boston, Boston, Massachusetts, United States
๐บ๐ธGeorgia Retina, Marietta, Georgia, United States
Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.
- Conditions
- Retinal Neovascularization
- First Posted Date
- 2020-12-03
- Last Posted Date
- 2021-11-29
- Lead Sponsor
- Notal Vision Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT04650672
- Locations
- ๐บ๐ธ
Ophthalmic Cons. of Boston, Boston, Massachusetts, United States
๐บ๐ธPepose Vision Institute, Saint Louis, Missouri, United States
Single In-Clinic Encounter With the Notal Vision Home OCT
- Conditions
- Neovascular Age-related Macular DegenerationIntermediate Age Related Macular Degeneration (Disorder)
- First Posted Date
- 2020-11-24
- Last Posted Date
- 2021-12-23
- Lead Sponsor
- Notal Vision Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT04642183
- Locations
- ๐บ๐ธ
Elman Retina Group, PA, Baltimore, Maryland, United States